{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-125418","form_type":"8-K","ticker":"CTOR","cik":"0001851484","company_name":"CITIUS ONCOLOGY, INC.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.812272+00:00","generated_at":"2026-05-16T12:18:39.151330+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Citius Oncology reports FY 2025 net loss of $24.8M; launches LYMPHIR in U.S.","bullets":["Net loss of $24.8M ($0.34 per share) vs $21.1M ($0.31) in FY 2024, driven by pre-commercial investment.","Cash and equivalents $3.9M as of Sep 30, 2025; raised $36M in three financings post- and intra-year.","LYMPHIR launched in U.S. Dec 2025; distribution agreements with top three wholesalers secured.","International access via Named Patient Programs in 19 markets; collaboration with Verix for AI-driven commercial targeting.","R&D expense $6.4M (up from $4.9M); G&A $8.8M ($8.1M prior); stock-based comp $8.3M ($7.5M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-125418","json":"https://secwatch.observer/filing/0001213900-25-125418.json","markdown":"https://secwatch.observer/filing/0001213900-25-125418.md","text":"https://secwatch.observer/filing/0001213900-25-125418.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025125418/0001213900-25-125418-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025125418/ea0270775-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:18:39.151330+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}